kneat.com Inc KSI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KSI is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CAD 4.12
- Day Range
- CAD 3.98–4.15
- 52-Week Range
- CAD 2.52–4.50
- Bid/Ask
- CAD 3.68 / CAD 4.45
- Market Cap
- CAD 351.86 Mil
- Volume/Avg
- 185,474 / 42,667
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.75
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
kneat.com Inc is in the business of developing and marketing a software application for modeling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed the Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance, which include product support services. The company geographically operates in North America, Europe and Asia Pacific, out of which it earns maximum revenue from North America.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 293
- Website
- https://www.kneat.com
Comparables
Valuation
|
Metric
|
KSI
|
AVDX
|
NORDH
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 61.97 | — |
Price/Book Value | 11.19 | 3.38 | 2.97 |
Price/Sales | 8.75 | 5.58 | 6.24 |
Price/Cash Flow | — | 45.58 | 229.81 |
Price/Earnings
KSI
AVDX
NORDH
Financial Strength
|
Metric
|
KSI
|
AVDX
|
NORDH
|
|---|---|---|---|
Quick Ratio | 1.53 | 0.39 | 2.39 |
Current Ratio | 1.57 | 1.34 | 2.39 |
Interest Coverage | −6.90 | −2.99 | −1,270.38 |
Quick Ratio
KSI
AVDX
NORDH
Profitability
|
Metric
|
KSI
|
AVDX
|
NORDH
|
|---|---|---|---|
Return on Assets (Normalized) | −21.78% | 0.57% | −10.46% |
Return on Equity (Normalized) | −61.25% | 1.89% | −11.87% |
Return on Invested Capital (Normalized) | −32.70% | 0.81% | −12.17% |
Return on Assets
KSI
AVDX
NORDH
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Vlwrxv | $37.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Sbnnyblkdx | Cqtn | $34.0 Bil | |
SOLV
| Solventum Corp | — | Llzzws | $10.6 Bil | |
PMCUF
| Pro Medicus Ltd | — | Nbfkl | $7.8 Bil | |
HQY
| HealthEquity Inc | — | Ktyttzq | $6.9 Bil | |
MTHRF
| M3 Inc | — | Phnvz | $6.9 Bil | |
MTHRY
| M3 Inc ADR | — | Ysqbf | $6.9 Bil | |
DOCS
| Doximity Inc Class A | — | Mbcvspx | $5.4 Bil | |
RCM
| R1 RCM Inc | — | Pzs | $5.2 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Khnw | $2.9 Bil |